Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03911557
Title Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors John L. Villano, MD, PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST